Abstract Number: 0574 • ACR Convergence 2020
Is Hydroxychloroquine Use a Proxy for Health Care Access? Predictors of First Dispensing Among Medicaid Beneficiaries with Incident Lupus
Background/Purpose: Hydroxychloroquine/chloroquine (HCQ/CQ) is considered to be the backbone of systemic lupus erythematosus (SLE) care. Differences in receipt of HCQ/CQ may exacerbate disparities in adverse…Abstract Number: 0603 • ACR Convergence 2020
Multisite Study of the Impact of COVID-19 Era Telemedicine Expansion on Reduction in No-Show Rates
Background/Purpose: The COVID-19 pandemic led to rapid expansion of telemedicine in all fields, including rheumatology. We hypothesized that increased use of telemedicine would reduce no-show…Abstract Number: 1586 • ACR Convergence 2020
Rheum Service: Comprehensive Virtual Care During COVID-19
Background/Purpose: During COVID-19, patients require timely access to rheumatologists while adhering to physical distancing guidelines. In this quality improvement project, we developed a comprehensive virtual…Abstract Number: 1588 • ACR Convergence 2020
A Quality Improvement Project to Improve Bone Densitometry Ordering in Adult Patients on Chronic Glucocorticoids
Background/Purpose: The 2017 ACR guideline for glucocorticoid-induced osteoporosis (GIOP) recommends DXA testing in patients aged ≥40 years on chronic glucocorticoids. We performed a quality improvement…Abstract Number: 278 • 2019 ACR/ARP Annual Meeting
Improving a SLE-Quality Indicator Tool in an Outpatient Tertiary Care Setting
Background/Purpose: The care for patients with lupus is complex as they may exhibit multiple concomitant medical and socioeconomic issues. To address all their needs according…Abstract Number: 1192 • 2019 ACR/ARP Annual Meeting
Effect of a Clinical Decision Support System on a Quality Indicator of Glucocorticoid-induced Osteoporosis and Trends of Drug Treatment in a Japanese Hospital
Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is a common, preventable and treatable complication of glucocorticoid therapy. We defined quality indicator (QI) for GIOP and took a hospital-wide…Abstract Number: 1178 • 2018 ACR/ARHP Annual Meeting
Patients’ and Healthcare Professionals’ Resource Preferences for a Knowledge Translation Toolkit for Hip and Knee Replacement Rehabilitation
Background/Purpose: Widely varying rehabilitation practices for total joint replacement (TJR) for hip and knee osteoarthritis (OA) contribute to inconsistent patient outcomes and satisfaction. Informed by…Abstract Number: 2960 • 2018 ACR/ARHP Annual Meeting
Evaluation of Performance Measures Reveals Delays and Sub-Optimal Access to Rheumatology Care and Treatment
Background/Purpose: Early diagnosis, treatment and ongoing care are critical to optimize RA outcomes. The purpose of the study was to evaluate key elements of RA…Abstract Number: 1085 • 2017 ACR/ARHP Annual Meeting
Application of Lupus Nephritis Quality Measures to Understand Gaps in Care for SLE
Background/Purpose: In 2012, the ACR released guidelines for monitoring and treatment of lupus nephritis (LN), but studies have yet to evaluate adherence to these recommendations.…Abstract Number: 1593 • 2017 ACR/ARHP Annual Meeting
Development of Quality Indicator Set of Systemic Lupus Erythematosus in Japan
Background/Purpose: A QI set for systemic lupus erythematosus (SLE) was developed in the United States. However, this does not necessarily conform to the Japanese medical…Abstract Number: 21 • 2017 Pediatric Rheumatology Symposium
Enhancing Quality of Care in Childhood-Onset Systemic Lupus Erythematosus by Improving Performance on Quality Indicator Measures in Cardiovascular and Bone Health
Background/Purpose: Childhood-onset SLE (cSLE) leads to poor health outcomes, including cardiovascular and bone health, due to high rates of potentially devastating disease complications and medication…Abstract Number: 1404 • 2016 ACR/ARHP Annual Meeting
Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis
Background/Purpose: Quality measures are metrics health professionals can monitor to improve care delivery and patient outcomes. To be measurable they must include a specified numerator,…Abstract Number: 2247 • 2016 ACR/ARHP Annual Meeting
REAL-Life Cost of UK Healthcare Resource for Patients with Rheumatoid Arthritis, Comparing High and Low/Remission Disease States
Background/Purpose: Rheumatoid Arthritis (RA) has differing therapeutic outcomes, with resulting differences in function and quality of life. Little is known about the effects of disease…Abstract Number: 368 • 2015 ACR/ARHP Annual Meeting
The Effects of Monitoring on a Quality Indicator for Glucocorticoid–Induced Osteoporosis and Trends of the Drug Variation in a Japanese Hospital
Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is one of the most clinically significant side effects of glucocorticoid use, and the prevention of GIOP has become more important…Abstract Number: 999 • 2015 ACR/ARHP Annual Meeting
Development of Quality Indicators for Hip and Knee Arthroplasty Rehabilitation
Background/Purpose: Rehabilitation before and after total hip (THA) and knee arthroplasty (TKA) surgery has been shown to decrease pain and impairment, and improve mobility, activity…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- Next Page »